Peptide receptor radionuclide therapy after NETTER-1 clinical trial: what should not be left behind Maccauro MarcoCapozza AntonellaSeregni Ettore Editorial 15 May 2019 Pages: 155 - 157
Predictive value of pre-treatment FDG PET in patients with non-Hodgkin lymphoma treated with radioimmunotherapy: a systematic review Silvia MorbelliSelene CapitanioLuigi Rigacci Systematic Review 11 June 2019 Pages: 159 - 170
Current status of SSR-directed imaging and therapy in meningioma M. UnterrainerM. NiyaziN. L. Albert Expert Review 08 June 2019 Pages: 171 - 180
Combined 68Ga-DOTA-peptides and 18F-FDG PET in the diagnostic work-up of neuroendocrine neoplasms (NEN) Francesca MuffattiStefano PartelliMassimo Falconi Systematic Review 03 June 2019 Pages: 181 - 188
Recent developments of prostate-specific membrane antigen (PSMA)-specific radiopharmaceuticals for precise imaging and therapy of prostate cancer: an overview Subhani M. Okarvi Expert Review 18 May 2019 Pages: 189 - 208
Role of thyroglobulin in the management of patients with differentiated thyroid cancer Seong Young KwonYingjie ZhangHee-Seung Bom Expert Review 15 May 2019 Pages: 209 - 217
18F-FDG in the presurgical evaluation of epilepsies: a pictorial essay Angelo Del SoleChiara PastoriLaura Tassi Pictorial Essay 16 April 2019 Pages: 219 - 229
Correction to: The role of molecular imaging in the frame of the revised dementia with Lewy body criteria Stelvio SestiniPierpaolo AlongiFlavio Nobili Correction 06 May 2019 Pages: 231 - 231